Viral respiratory disease in athletic horses

Equine Sports Medicine and Surgery

Volumn , Issue , 2004, Pages 657-673

  Morley, Paul ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882523432     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7020-2671-3.50034-9     Document Type: Chapter

References (105)

1. Bailey CJ, Rose RJ, Reid SW, Hodgson DR Wastage in the Australian thoroughbred racing industry: a survey of Sydney trainers. Aust Vet J 1997, 75(1):64-66.
2. Bailey CJ, Reid SW, Hodgson DR, Rose RJ Impact of injuries and disease on a cohort of two- and three-year-old thoroughbreds in training. Vet Rec 1999, 145(17):487-493.
3. Hernandez J, Hawkins DL Training failure among yearling horses. Am J Vet Res 2001, 62(9):1418-1422.
4. Ryan AJ, Dalrymple W, Dull B, et al. Round table: Upper respiratory infections in sports. Phys Sports Med 1975, 3:29-42.
5. Hanley DF Medical care of the US Olympic Team. JAMA 1976, 236(2):147-148.
6. Weidner TG Literature review: upper respiratory illness and sport and exercise. Int J Sports Med 1994, 15(1):1-9.
7. Weidner TG, Anderson BN, Kaminsky LA, et al. Effect of a rhinovirus-caused upper respiratory illness on pulmonary function test and exercise responses. Med Sci Sports Exerc 1997, 29:604-609.
8. Morley PS. The epidemiology of infectious upper respiratory tract disease in horses. PhD dissertation, University of Saskatchewan, 1995.
9. NAHMS NAHMS Equine '98: Needs Assessment Survey Results. #N207.597. 1997. Online. Available at (accessed 11 April 2003) . http://www.aphis.usda.gov/vs/ceah/cahm/Equine/eq98na.pdf.
10. Traub-Dargatz JL, Salman MD, Voss JL Medical problems of adult horses, as ranked by equine practitioners. J Am Vet Med Assoc 1991, 198(10):1745-1747.
11. Peters EM, Bateman ED Ultramarathon running and upper respiratory tract infections. S Afr Med J 1983, 64:582-584.
12. Weigl JA, Puppe W, Schmitt HJ The incidence of influenza-associated hospitalizations in children in Germany. Epidemiol Infect 2002, 129(3):525-533.
13. Zimmerman RK, Middleton DB, Smith NJ Vaccines for persons at high risk due to medical conditions, occupation, environment, or lifestyle, 2003. J Fam Pract 2003, 52(1 Suppl):S22-S35.
14. Clarke AF, Madelin TM, Allpress RG The relationship of air hygiene in stables to lower airway disease and pharyngeal lymphoid hyperplasia in 2 groups of thoroughbred horses. Equine Vet J 1987, 19(6):524-530.
15. Clarke AF, Madelin TM, Allpress RG. The relationship of air hygiene in stables to lower airway disease during an outbreak of equid herpesvirus-1 infection. In: Equine infectious diseases V: Proceedings of the Fifth International Conference on Equine Infectious Diseases. Lexington, KY: University Press of Kentucky; 1988; 268-271.
16. Nieman DC Special feature for the Olympics: effects of exercise on the immune system: exercise effects on systemic immunity. Immunol Cell Biol 2000, 78(5):496-501.
17. Gleeson M, Pyne DB Exercise effects on mucosal immunity. Immunol Cell Biol 2000, 78(5):536-544.
18. Gleeson M, Pyne DB Special feature for the Olympics: effects of exercise on the immune system: exercise effects on mucosal immunity. Immunol Cell Biol 2000, 78(5):536-544.
19. Woods JA, Lu Q, Ceddia MA, Lowder T Exercise-induced modulation of macrophage function. Immunol Cell Biol 2000, 78(5):545-553.
20. Woods J, Lu Q, Ceddia MA, Lowder T Special feature for the Olympics: effects of exercise on the immune system: exercise-induced modulation of macrophage function. Immunol Cell Biol 2000, 78(5):545-553.
21. Jonsdottir IH, Hoffmann P The significance of intensity and duration of exercise on natural immunity in rats. Med Sci Sports Exerc 2000, 32(11):1908-1912.
22. Jonsdottir IH Exercise immunology: neuroendocrine regulation of Nk-cells. Int J Sports Med 2000, 21:S20-S23.
23. Jonsdottir IH Special feature for the Olympics: effects of exercise on the immune system: neuropeptides and their interaction with exercise and immune function. Immunol Cell Biol 2000, 78(5):562-570.
24. Pedersen BK, Ullum H Nk cell response to physical-activity -possible mechanisms of action. Med Sci Sports Exerc 1994, 26(2):140-146.
25. Nieman DC Is infection risk linked to exercise workload?. Med Sci Sports Exerc 2000, 32(7):S406-S411.
26. Pedersen BK, Bruunsgaard H How physical exercise influences the establishment of infections. Sports Med 1995, 19(6):393-400.
27. Lunn DP, Hussey S, Sebring R, et al. Safety, efficacy and immunogenicity of a modified-live equine influenza virus vaccine in ponies after induction of exercise-induced immunosuppression. J Am Vet Med Assoc 2001, 218(6):900-906.
28. Guo Y, Wang M, Kawaoka Y, et al. Characterization of a new avian-like influenza A virus from horses in China. Virology 1992, 188(1):245-255.
29. Guo Y, Wang M, Zheng GS, et al. Seroepidemiological and molecular evidence for the presence of two H3N8 equine influenza viruses in China in 1993-94. J Gen Virol 1995, 76:2009-2014.
30. Horohov DW, Keadle TL, Pourciau SS, et al. Mechanism of exercise-induced augmentation of lymphokine activated killer (Lak) cell activity in the horse. Vet Immunol Immunopathol 1996, 53(3-4):221-233.
31. Horohov DW, Dimock A, Guirnalda P, et al. Effect of exercise on the immune response of young and old horses. Am J Vet Res 1999, 60(5):643-647.
32. Kurcz EV, Lawrence LM, Kelley KW, Miller PA The effect of intense exercise on the cell-mediated immune-response of horses. J Equine Vet Sci 1988, 8:237-239.
33. Keadle TL, Pourciau SS, Melrose PA, et al. Acute exercise stress modulates immune function in unfit horses. J Equine Vet Sci 1993, 13:226-231.
34. Wong CW, Smith SE, Thong YH, et al. Effects of exercise stress on various immune functions in horses. Am J Vet Res 1992, 53:1414-1417.
35. Rose RJ Hematological-changes associated with endurance exercise. Vet Rec 1982, 110(8):175-177.
36. Snow DH, Ricketts SW, Mason DK Hematological response to racing and training exercise in thoroughbred horses, with particular reference to the leukocyte response. Equine Vet J 1983, 15(2):149-154.
37. Rose RJ, Hodgson DR Hematological and plasma biochemical parameters in endurance horses during training. Equine Vet J 1982, 14(2):144-148.
38. Shephard RJ Special feature for the Olympics: effects of exercise on the immune system: overview of the epidemiology of exercise immunology. Immunol Cell Biol 2000, 78(5):485-495.
39. Morley PS, Townsend HG, Bogdan JR, Haines DM Descriptive epidemiologic study of disease associated with influenza virus infections during three epidemics in horses. J Am Vet Med Assoc 2000, 216(4):535-544.
40. NAHMS Infectious upper respiratory disease in US horses: disease frequency. #N342.1001, 2001. Online. Available at (accessed 11 April 2003) . http://www.aphis.usda.gov/vs/ceah/cahm/Equine/iurd98.pdf.
41. Kaneene JB, Saffell M, Fedewa DJ, et al. The Michigan Equine Monitoring System. 1. Design, implementation and population estimates. Prev Vet Med 1997, 29(4):263-275.
42. Burrell MH, Wood JL, Whitwell KE, et al. Respiratory disease in thoroughbred horses in training: the relationships between disease and viruses, bacteria and environment. Vet Rec 1996, 139(13):308-313.
43. Gross DK, Hinchcliff KW, French PS, et al. Effect of moderate exercise on the severity of clinical signs associated with influenza virus infection in horses. Equine Vet J 1998, 30(6):489-497.
44. Morley PS, Townsend HG, Bogdan J, et al. Infectious upper respiratory tract disease caused by influenza virus in horses stabled at a racetrack. Proc Am Assoc Equine Pract 1995, 41:174-175.
45. Marois P, Pavilanis V, Boudreault A, Di Franco E An outbreak of Type A2 influenza among horses. Can J Comp Med 1963, 27:257-260.
46. McQueen JL. Review of influenza in animals: Equine. CDC Zoonoses Surveillance. Special Report: Animal Influenza 1965; Report #5:6-13.
47. Aiello SE, Mays A, eds. The Merck Veterinary Manual - Equine Influenza. Online. Available at (accessed 11 April 2003) . http://www.merckvetmanual.com/mvm/index.jsp?cfile=htm/bc/121304.htm&word=equine%2cinfluenza.
48. Handistatus II. Online. Available at (accessed 11 April 2003) . http://www.oie.int/hs2/report.asp?lang=en.
49. Rees WA, Harkins JD, Lu M, et al. Pharmacokinetics and therapeutic efficacy of rimantadine in horses experimentally infected with influenza virus A2. Am J Vet Res 1999, 60:888-894.
50. Mumford JA, Hannant D Equine influenza. Virus infections of equines 1996, 285-294. Elsevier, New York. M.J. Studdert (Ed.).
51. Maisch B, Ristic AD, Portig I, Pankuweit S Human viral cardiomyopathy. Front Biosci 2003, 8:S39-S67.
52. Mumford EL, Traub-Dargatz JL, Salman MD, et al. Monitoring and detection of acute viral respiratory tract disease in horses. J Am Vet Med Assoc 1998, 213(3):385-390.
53. Morley PS, Bogdan JR, Townsend HG, Haines DM Evaluation of Directigen Flu A assay for detection of influenza antigen in nasal secretions of horses. Equine Vet J 1995, 27(2):131-134.
54. Chambers TM, Shortridge KF, Li PH, et al. Rapid diagnosis of equine influenza by the Directigen FLU-A enzyme immunoassay. Vet Rec 1994, 135(12):275-279.
55. Townsend HGG, Moore SL, Bogdan JR, et al. Evaluation of an optical immunoassay for the diagnosis of equine influenza. In: Salman MD, Morley PS, Ruch-Gallie R, eds. Proceedings of the 9th Symposium of the International Society for Veterinary Epidemiology and Economics. International Society for Veterinary Epidemiology and Economics, 2000; Abstract number 508.
56. Adam EN, Morley PS, Chmielewski KE, et al. Detection of cold-adapted vaccine-strain influenza virus using two commercial assays. Equine Vet J 2002, 34(4):400-404.
57. Powell DG, Burrows R, Spooner PR, et al. A study of infectious respiratory disease among horses in Great Britain, 1971-1976. In: Bryans JT, ed. Equine infectious diseases IV: Proceedings of the Fourth International Conference on Equine Infectious Diseases. Princeton, NJ: Veterinary Publications; 1978; 451-459.
58. Ostlund EN, Powell D, Bryans JT Equine herpesvirus 1: A review. Proc Am Assoc of Equine Pract 1991, 36:387-395.
59. Burrows R, Goodridge D, Denyer M, et al. Equine influenza infections in Great Britain, 1979. Vet Rec 1982, 110:494-497.
60. Browning GF, Agius CT Equine herpesvirus 2 and 5 infections. Virus infections of equines 1996, 47-62. Elsevier, New York. M.J. Studdert (Ed.).
61. Wood JL, Burrell MH, Roberts CA, et al. Streptococci and Pasteurella spp. associated with disease of the equine lower respiratory tract. Equine Vet J 1993, 25(4):314-318.
62. Ward CL, Wood JL, Houghton SB, et al. Actinobacillus and Pasteurella species isolated from horses with lower airway disease. Vet Rec 1998, 143(10):277-279.
63. Rees WA, Harkins JD, Woods WE, et al. Amantadine and equine influenza: pharmacology, pharmacokinetics and neurological effects in the horse. Equine Vet J 1997, 29(2):104-110.
64. Gibson JS, Slater JD, Field HJ The activity of (S)-1-[(3-hydroxy-2-phosphonyl methoxy)propyl] cytosine (HPMPC) against equine herpesvirus-1 (EHV-1) in cell cultures, mice and horses. Antiviral Res 1992, 19(3):219-232.
65. Morley PS Biosecurity of veterinary practices. Vet Clin North Am Food Anim Pract 2002, 18(1):133-155.
66. Traub-Dargatz JL, Morley PS, Dargatz DA, et al. Infection control strategies in horses for the new millennium. Proc Am Assoc Equine Pract 2000, 46:36-41.
67. Townsend HG, Penner SJ, Watts TC, et al. Efficacy of a cold-adapted, intranasal, equine influenza vaccine: challenge trials. Equine Vet J 2001, 33(7):637-643.
68. Kastner SB, Haines DM, Archer J, Townsend HG Investigations on the ability of clenbuterol hydrochloride to reduce clinical signs and inflammation associated with equine influenza A infection. Equine Vet J 1999, 31(2):160-168.
69. Anon 963 Equine influenza epizootic. J Am Vet Med Assoc 1963, 143(10):1108.
70. Scholtens RG, Steele JH, Dowdle WR, et al. United-States epizootic of equine influenza, 1963. Public Health Rep 1964, 79(5):393-402.
71. Guthrie AJ, Stevens KB, Bosman PP The circumstances surrounding the outbreak and spread of equine influenza in South Africa. Rev Sci Tech 1999, 18(1):179-185.
72. Larson EL APIC guideline for handwashing and hand antisepsis in health care settings. Am J Infect Control 1995, 23(4):251-269.
73. Fotheringham VJ Disinfection of livestock production premises. Rev Sci Tech 1995, 14(1):191-205.
74. Ford WB Disinfection procedures for personnel and vehicles entering and leaving contaminated premises. Rev Sci Tech 1995, 14(2):393-401.
75. Dwyer RM Disinfecting equine facilities. Rev Sci Tech 1995, 14(2):403-418.
76. Antec International Ltd Animal health: equine menu. Online. Available at (accessed 11 April 2003) . http://www.antecint.co.uk/main/equine.htm.
77. Mumford JA, Jessett D, Dunleavy U, et al. Antigenicity and immunogenicity of experimental equine influenza ISCOM vaccines. Vaccine 1994, 12(9):857-863.
78. Mumford JA, Wilson H, Hannant D, Jessett DM Antigenicity and immunogenicity of equine influenza vaccines containing a Carbomer adjuvant. Epidemiol Infect 1994, 112(2):421-437.
79. Morley PS, Townsend HG, Bogdan JR, Haines DM Efficacy of a commercial vaccine for preventing disease caused by influenza virus infection in horses. J Am Vet Med Assoc 1999, 215(1):61-66.
80. Mumford EL, Traub-Dargatz JL, Carman J, et al. Occurrence of infectious upper respiratory tract disease and response to vaccination in horses on six sentinel premises in northern Colorado. Equine Vet J 2003, 35(1):72-77.
81. Ellis JA, Bogdan JR, Kanara EW, et al. Cellular and antibody responses to equine herpesviruses 1 and 4 following vaccination of horses with modified-live and inactivated viruses. J Am Vet Med Assoc 1995, 206(6):823-832.
82. Gerber JD, Marron AE, Bass EP, Beckenhauer WH Effect of age and pregnancy on the antibody and cell-mediated immune responses of horses to equine herpesvirus 1. Can J Comp Med 1977, 41(4):471-478.
83. Banks J, Speidel EC, McCauley JW, Alexander DJ Phylogenetic analysis of H7 haemagglutinin subtype influenza A viruses. Arch Virol 2000, 145(5):1047-1058.
84. Lai AC, Chambers TM, Holland RE, et al. Diverged evolution of recent equine-2 influenza (H3N8) viruses in the Western Hemisphere. Arch Virol 2001, 146(6):1063-1074.
85. Daly JM, Lai ACK, Binns MM, et al. Antigenic and genetic evolution of equine H3n8 influenza a viruses. J Gen Virol 1996, 77:661-671.
86. Yates P, Mumford JA Equine influenza vaccine efficacy: the significance of antigenic variation. Vet Microbiol 2000, 74(1-2):173-177.
87. Loke CT Outbreak of equine influenza in Malaysia and Singapore. Singapore Vet J 1981, 5:53-54.
88. Singh G A note on the concurrent isolation, from horses and ponies, of influenza A/EQ 1 and A/EQ 2 viruses from an epidemic of equine influenza in India. Comp Immunol Microbiol Infect Dis 1995, 18:73-74.
89. Webster RG, Guo Y New influenza virus in horses. Nature 1991, 351:527.
90. Mumford J, Wood J WHO/OIE meeting: consultation on newly emerging strains of equine influenza. 18-19 May 1992, Animal Health Trust, Newmarket, Suffolk, UK. Vaccine 1993, 11:1172-1175.
91. Sutton GA, Viel L, Carman PS, Boag BL Study of the duration and distribution of equine influenza virus subtype 2 (H3N8) antigens in experimentally infected ponies in vivo. Can J Vet Res 1997, 61(2):113-120.
92. Webster RG, Kawaoka Y, Guo Y Equine influenza in China. Foreign Animal Disease Report 1991, 19:3.
93. Powell DG, Watkins KL, Li PH, Shortridge KF Outbreak of equine influenza among horses in Hong Kong during 1992. Vet Rec 1995, 136(21):531-536.
94. Morley PS, Townsend HG, Bogdan JR, Haines DM Risk factors for disease associated with influenza virus infections during three epidemics in horses. J Am Vet Med Assoc 2000, 216(4):545-550.
95. Crabb BC, Studdert MJ Equine rhinopneumonitis and equine abortion (Equine herpesviruses 4 and 1). Virus infections of equines 1996, 11-38. Elsevier, New York. M.J. Studdert (Ed.).
96. Gilkerson J, Jorm LR, Love DN, et al. Epidemiological investigation of equid herpesvirus-4 (EHV-4) excretion assessed by nasal swabs taken from thoroughbred foals. Vet Microbiol 1994, 39(3-4):275-283.
97. Dunowska M, Wilks CR, Studdert MJ, Meers J Equine respiratory viruses in foals in New Zealand. New Zealand Vet J 2002, 50(4):140-147.
98. Murray MJ, Eichorn ES, Dubovi EJ, et al. Equine herpesvirus type 2: prevalence and seroepidemiology in foals. Equine Vet J 1996, 28(6):432-436.
99. Borchers K, Wolfinger U, Goltz M, et al. Distribution and relevance of equine herpesvirus type 2 (EHV-2) infections. Arch Virol 1997, 142(5):917-928.
100. Dunowska M, Wilks CR, Studdert MJ, Meers J Viruses associated with outbreaks of equine respiratory disease in New Zealand. New Zealand Vet J 2002, 50(4):132-139.
101. Dunowska M, Holloway SA, Wilks CR, Meers J Genomic variability of equine herpesvirus-5. Arch Virol 2000, 145(7):1359-1371.
102. NAHMS Equine Viral Arteritis (EVA) and the US Horse Industry. #N312.0501. 2000. Online. Available at . (accessed 11 April 2003) . http://www.aphis.usda.gov/vs/ceah/cahm/Equine/eq98eva.pdf.
103. Newton JR, Wood JL, Castillo-Olivares FJ, Mumford JA Serological surveillance of equine viral arteritis in the United Kingdom since the outbreak in 1993. Vet Rec 1999, 145(18):511-516.
104. Equine Viral Arteritis Protocol. 2000. Online. Available at (accessed 11 April 2003) . http://www.horsecouncil.org/health/evaproto.html.
105. De Vries AAF, Rottier PJM, Glaser AL, Horzinek MC Equine viral arteritis. Virus infections of equines 1996, 171-200. Elsevier, New York. M.J. Studdert (Ed.).